Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.
Ontology highlight
ABSTRACT: Dystroglycan is frequently lost in adenocarcinoma, but the mechanisms and consequences are poorly understood. We report an analysis of β-dystroglycan in prostate cancer in human tissue samples and in LNCaP cells in vitro. There is progressive loss of β-dystroglycan immunoreactivity from basal and lateral surfaces of prostate epithelia which correlates significantly with increasing Gleason grade. In about half of matched bone metastases there is significant dystroglycan re-expression. In tumour tissue and in LNCaP cells there is also a tyrosine phosphorylation-dependent translocation of β-dystroglycan to the nucleus. Analysis of gene expression data by microarray, reveals that nuclear targeting of β-dystroglycan in LNCaP cells alters the transcription of relatively few genes, the most unreg
SUBMITTER: Mathew G
PROVIDER: S-EPMC3786294 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA